Trial Profile
Concurrent vs sequential therapy with rituximab and CHOP in patients with indolent B-cell non-Hodgkin's lymphoma
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 09 Mar 2011
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Follicular lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.